BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36250993)

  • 21. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia.
    Wong IH; Chan J; Wong J; Tam PK
    Clin Cancer Res; 2004 Feb; 10(3):994-1002. PubMed ID: 14871978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
    Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
    Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors.
    Horiguchi K; Tomizawa Y; Tosaka M; Ishiuchi S; Kurihara H; Mori M; Saito N
    Oncogene; 2003 Oct; 22(49):7862-5. PubMed ID: 14586413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma.
    Guo W; Cui L; Wang C; Guo Y; Shen S; Kuang G; Dong Z
    Clin Exp Metastasis; 2014 Jun; 31(5):521-33. PubMed ID: 24756244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdoid tumor of the kidney in children: a comparative study of 21 cases.
    Agrons GA; Kingsman KD; Wagner BJ; Sotelo-Avila C
    AJR Am J Roentgenol; 1997 Feb; 168(2):447-51. PubMed ID: 9016225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
    Gharanei S; Brini AT; Vaiyapuri S; Alholle A; Dallol A; Arrigoni E; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
    Epigenetics; 2013 Sep; 8(9):893-8. PubMed ID: 23887284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
    Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
    Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data.
    Koh KN; Han JW; Choi HS; Kang HJ; Lee JW; Yoo KH; Sung KW; Koo HH; Hong KT; Choi JY; Kang SH; Kim H; Im HJ; Hahn SM; Lyu CJ; Baek HJ; Kook H; Park KM; Yang EJ; Lim YT; Kim S; Lee JW; Chung NG; Cho B; Park M; Park HJ; Park BK; Lee JA; Park JE; Kim SK; Kim JY; Kim HS; Ma Y; Park KD; Park SK; Park ES; Shim YJ; Yoo ES; Ryu KH; Yoo JW; Lim YJ; Yoon HS; Lee MJ; Lee JM; Jeon IS; Jung HL; Chueh HW; Won S;
    Cancer Res Treat; 2023 Jan; 55(1):279-290. PubMed ID: 35952715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors.
    Malpeli G; Amato E; Dandrea M; Fumagalli C; Debattisti V; Boninsegna L; Pelosi G; Falconi M; Scarpa A
    BMC Cancer; 2011 Aug; 11():351. PubMed ID: 21838870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rare childhood kidney tumors].
    Vokuhl C
    Pathologe; 2019 Nov; 40(6):600-608. PubMed ID: 31338565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation influences the CTCF-modulated transcription of RASSF1A in lung cancer cells.
    Xie B; Peng F; He F; Cheng Y; Cheng J; Zhou Z; Mao W
    Cell Biol Int; 2022 Nov; 46(11):1900-1914. PubMed ID: 35989484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Study of Decitabine Effect on the Endometrial Carcinoma Xenografted in Nude Mice.].
    Li RH; Wang XP; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):843-847. PubMed ID: 28598109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
    Zhao QZ; Dou KF
    J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
    Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G
    J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.